ADIPOQ and type 2 diabetes mellitus: However, circulating FGF21 levels are increased, whereas adiponectin concentrations are reduced in subjects with type 2 diabetes [8, 9, 15], suggesting dysfunction of the FGF21-adiponectin pathway.